Why is Bliss GVS Pharma falling/rising?

As of 05-Aug, Bliss GVS Pharma Ltd is currently priced at 179.40, reflecting a decrease of 0.45, or 0.25%. Despite this slight decline, the stock has shown strong performance in recent periods, with a 14.49% increase over the past week and a 14.74% rise over the past month. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive trend. However, there has been a notable drop in investor participation, with delivery volume falling by 63.52% compared to the 5-day average, which may be contributing to the current price movement. Unfortunately, there is no information available regarding specific positive or negative factors impacting the stock.
In the broader market context, Bliss GVS Pharma has outperformed the Sensex, which has declined by 0.77% over the past week. The stock's year-to-date performance is also favorable, with an 8.96% increase compared to the Sensex's 3.29% rise. This suggests that while the stock is experiencing a minor decline today, its overall trend remains strong relative to the benchmark, particularly in the short term. The liquidity of the stock remains sufficient for trading, which could support its performance moving forward despite the recent drop in delivery volume.